Daryl Okamura is a Nephrology physician affiliated with University of Washington. OpenAlex indexes 55 publications with 1,899 citations (h-index 22).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4800 Sand Point Way NE
Seattle, WA 981053901
Telephone
206-987-2000Registry record last updated 2 Feb 2009.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year20241 payment
- Horizon Therapeutics plcProgram year20211 payment
- Travere Therapeutics, Inc.Program year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
2 NIH research awards on record, funded 2006–2010 per NIH RePORTER. The latest:
- Uncovering CD36-mediated oxidative and inflammatory pathways in progressive renal
Seattle Children'S Hospital
FY2010$96,525R03DK083648 - Multifunctional role CD36 in progressive renal fibrosis
Seattle Children'S Hospital
FY2009$128,250K08DK073497 - Uncovering CD36-mediated oxidative and inflammatory pathways in progressive renal
Seattle Children'S Hospital
FY2009$97,500R03DK083648
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The response to kidney injury is epigenetically regulated through the activation of bivalent genes
American Journal of Physiology-Renal Physiology
2026 - ECM-Focused Proteomic Analysis of Ear Punch Regeneration in <i>Acomys cahirinus</i>
Journal of Proteome Research
2025 - Childhood-onset lupus nephritis is characterized by complex interactions between kidney stroma and infiltrating immune cells
Science Translational Medicine
2024 - Efficacy and Safety of Pharmacokinetically-Driven Dosing of Mycophenolate Mofetil for the Treatment of Pediatric Proliferative Lupus Nephritis-A Double-Blind Placebo Controlled Clinical Trial (The Pediatric Lupus Nephritis Mycophenolate Mofetil Study).
PubMed
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Neal Futran, MD, DMD
University of Washington
Elizabeth Swisher
University of Washington
David Tirschwell
University of Washington
Elaine Peskind, MD
University of Washington
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”